|
ZC3H6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.015600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.057200E-01 |
| Normal-vs-Stage2 |
4.631800E-01 |
| Normal-vs-Stage3 |
8.036300E-04 |
| Normal-vs-Stage4 |
7.79360000000562E-05 |
| Stage1-vs-Stage2 |
6.400200E-01 |
| Stage1-vs-Stage3 |
3.823900E-04 |
| Stage1-vs-Stage4 |
2.35100000000044E-05 |
| Stage2-vs-Stage3 |
1.027790E-01 |
| Stage2-vs-Stage4 |
4.310300E-02 |
| Stage3-vs-Stage4 |
5.286400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.856300E-02 |
| Normal-vs-AfricanAmerican |
1.697800E-02 |
| Normal-vs-Asian |
1.072780E-01 |
| Caucasian-vs-AfricanAmerican |
2.845000E-01 |
| Caucasian-vs-Asian |
4.517800E-02 |
| AfricanAmerican-vs-Asian |
1.381890E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.499500E-02 |
| Normal-vs-Female |
3.622200E-02 |
| Male-vs-Female |
4.070400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.403000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.645200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.190280E-02 |
| Normal-vs-Age(81-100Yrs) |
2.006200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.364600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.156400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.654200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.154000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.226020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.129200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.957800E-01 |
| Normal-vs-Grade 2 |
9.835200E-01 |
| Normal-vs-Grade 3 |
3.404800E-03 |
| Normal-vs-Grade 4 |
6.78559999967021E-07 |
| Grade 1-vs-Grade 2 |
4.064200E-01 |
| Grade 1-vs-Grade 3 |
1.181720E-02 |
| Grade 1-vs-Grade 4 |
7.379900E-03 |
| Grade 2-vs-Grade 3 |
5.197000E-04 |
| Grade 2-vs-Grade 4 |
2.25299999767614E-08 |
| Grade 3-vs-Grade 4 |
4.722900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.156800E-01 |
| Normal-vs-ccB subtype |
1.280210E-02 |
| ccA subtype-vs-ccB subtype |
3.839200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.693550E-01 |
| Normal-vs-N1 |
2.344700E-03 |
| N0-vs-N1 |
2.536800E-03 |
|
|
